New functional test for the TFPIα cofactor activity of Protein S working in synergy with FV-Short

被引:13
作者
Dahlback, Bjorn [1 ]
Guo, Li Jun [1 ]
Zoller, Bengt [2 ]
Tran, Sinh [1 ]
机构
[1] Lund Univ, Skane Univ Hosp, Dept Translat Med, Inga Marie Nilssons St 53, S-21428 Malmo, Sweden
[2] Lund Univ, Skane Univ Hosp, Dept Clin Sci, Malmo, Sweden
基金
瑞典研究理事会;
关键词
deep venous thrombosis; factor V; factor X; protein S; TFPI; TISSUE FACTOR PATHWAY; C4B-BINDING PROTEIN; FACTOR-V; INHIBITOR-ALPHA; COAGULATION; INSIGHTS; DOMAINS; ISOFORMS; BIOLOGY; XA;
D O I
10.1111/jth.14405
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Protein S is an anticoagulant cofactor to both activated protein C and tissue factor pathway inhibitor (TFPI alpha). The TFPI alpha-cofactor activity of protein S is stimulated by a short isoform of factor V (FV-Short), the two proteins functioning in synergy. Objective Using the synergistic TFPI alpha-cofactor activity between protein S and FV-Short to develop a functional test for plasma protein S. Patients/Methods TFPI alpha-mediated inhibition of FXa in the presence of FV-Short, protein S and negatively charged phospholipid vesicles was monitored in time by synthetic substrate S2765. TFPI alpha, FXa and FV-Short were purified proteins, whereas diluted plasma from protein S deficient patients or controls were used as source for protein S. Results The assay was specific for free protein S demonstrating good correlation to free protein S plasma levels (r = 0.92) with a Y-axis intercept of -5%. Correlation to concentrations of total protein S (free and C4BP beta+-bound) was lower (r = 0.88) and the Y-axis intercept was +46%, which is consistent with the specificity for free protein S. The test distinguished protein S-deficient individuals from 6 families with known ProS1 mutations from family members having no mutation. Protein S levels of warfarin-treated protein S deficient cases were lower than protein S in cases treated with warfarin for other causes. Conclusions We describe a new assay measuring the TFPI alpha-cofactor activity of plasma protein S. The test identifies type I/III protein S deficiencies and will be a useful tool to detect type II protein S deficiency having defective TFPI alpha-cofactor activity.
引用
收藏
页码:585 / 595
页数:11
相关论文
共 42 条
[1]   New functional assays to selectively quantify the activated protein C- and tissue factor pathway inhibitor-cofactor activities of protein S in plasma [J].
Alshaikh, N. A. ;
Rosing, J. ;
Thomassen, M. C. L. G. D. ;
Castoldi, E. ;
Simioni, P. ;
Hackeng, T. M. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (05) :950-960
[2]   Tissue factor pathway inhibitor: structure-function [J].
Broze, George J., Jr. ;
Girard, Thomas J. .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2012, 17 :262-280
[3]   Lack of Protein S in mice causes embryonic lethal coagulopathy and vascular dysgenesis [J].
Burstyn-Cohen, Tal ;
Heeb, Mary Jo ;
Lemke, Greg .
JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (10) :2942-2953
[4]   Rethinking events in the haemostatic process: role of factor V and TFPI [J].
Camire, R. M. .
HAEMOPHILIA, 2016, 22 :3-8
[5]   PURIFICATION OF HUMAN VITAMIN-K-DEPENDENT PROTEIN-S AND ITS LIMITED PROTEOLYSIS BY THROMBIN [J].
DAHLBACK, B .
BIOCHEMICAL JOURNAL, 1983, 209 (03) :837-846
[6]   Blood coagulation [J].
Dahlback, B .
LANCET, 2000, 355 (9215) :1627-1632
[7]   Regulation of blood coagulation by the protein C anticoagulant pathway -: Novel insights into structure-function relationships and molecular recognition [J].
Dahlbäck, B ;
Villoutreix, BO .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (07) :1311-1320
[8]   Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S [J].
Dahlback, B. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (07) :1241-1250
[9]   VISUALIZATION OF HUMAN C4B-BINDING PROTEIN AND ITS COMPLEXES WITH VITAMIN-K-DEPENDENT PROTEIN-S AND COMPLEMENT PROTEIN-C4B [J].
DAHLBACK, B ;
SMITH, CA ;
MULLEREBERHARD, HJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (11) :3461-3465
[10]   Advances in understanding pathogenic mechanisms of thrombophilic disorders [J].
Dahlback, Bjorn .
BLOOD, 2008, 112 (01) :19-27